Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-d

Collaboration brings together Century’s industry leading iPSC-derived allogeneic cell therapy platform with Bristol Myers Squibb’s expertise in cell therapy and oncology drug developmentFirst two programs include a program in acute myeloid leukemia and a program in multiple myeloma, which could incorporate either th...

Related Keywords

Japan ,United States ,Philadelphia ,Pennsylvania ,Japanese ,Lalo Flores ,Nina Goworek ,Joshuar Mansbach ,Rupert Vessey ,Elizabeth Krutoholow ,Bristol Myers Squibb ,Melissa Forst Maghan Meyers ,Instagram ,Linkedin ,Research Early Development ,Twitter ,Fujifilm ,Exchange Commission ,Youtube ,Facebook ,Century Therapeutics ,Myers Squibb ,Chief Executive Officer ,Executive Vice President ,Early Development ,Bristol Myers ,Century Therapeutic ,Better Future ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Therapeutics Contact ,Maghan Meyers ,